Class action against Merck Co

$MRK (-1.51%)

Class action lawsuit against Merck & Co, Inc. This lawsuit involves investors who purchased Merck securities between February 3, 2022 and February 3, 2025. The allegation is that Merck published misleading information about the expected revenue of the HPV vaccine Gardasil. On February 4, 2025, Merck announced that the projected sales of USD 11 billion by 2030 will not be achieved and that shipments to China will be temporarily discontinued, resulting in a share price decline of over 9%.

https://securitiesclasslaw.com/securities/merck-co-inc-loss-submission-form/

TeePee@TeePee

1Wk

I wouldn't go along with such nonsense. Even if the law firm successfully obtains a small amount, only it will profit from the various fees, while you will receive at most a tiny cash check whose redemption will cost you more fees in Europe than it is worth.

••

mami_goes_boerse@mami_goes_boerse

@TeePee It's also just an informative post. I personally wouldn't get involved either.

Class action against Merck & Co